A lab study pairs two drugs to kill glioblastoma cells
Original title: Targeting the NAD+ Salvage Pathway Blocks Metabolic Recovery and Enhances β-Lapachone Toxicity in NQO1-Expressing Glioblastoma Cells.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done on cells in a lab dish, not in people.
The short version
In lab dishes, blocking a cell's energy repair system made a test drug better at killing glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells.
What was studied. Researchers worked with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells grown in the lab, including a standard cell line and cells taken from patients. They compared these to normal human brain support cells, and tested a compound called beta-lapachone alone and with a second drug called FK866.
What they found. Many of the glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells made high levels of a protein called NQO1. Beta-lapachone killed those high NQO1 cells but mostly spared cells with low levels, including the normal brain cells. The tumor cells could rebuild a fuel molecule called NAD+ and survive, but adding FK866 blocked that rebuilding and made beta-lapachone more deadly to the tumor cells.
What this means, and what it doesn't
What it could mean: This points to a possible weak spot in some glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells. If a tumor makes a lot of NQO1, a drug pair like this might one day be used to attack it. Right now it is an idea that needs much more testing.
What it doesn't mean: This does not mean there is a new treatment. The work was done only on cells in dishes in a lab. It was not tested in animals or in people. It does not show that anyone lived longer or felt better. It is not a promise of a cure.
Source: PubMed, August 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.